Business · 06/02/2012
FDA Adopts Final Rule on Labeling Requirements for Products in Strategic National Stockpile
The FDA is finalizing a rule allowing FDA Center Directors to grant exceptions or alternatives to certain labeling requirements for human drugs, biological products, or medical devices held in the Strategic National Stockpile.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →